NCT07204002

Brief Summary

Benign prostatic enlargement (BPH/BPS) is one of the most common benign diseases in adult men. About 50% of men are affected by the age of 50, and between the ages of 70 and 80 the prevalence rises to 70-80%. There are various surgical procedures available for the treatment of BPH. In this study, we are investigating three surgical procedures which, based on the current data, appear to be relatively equivalent; however, additional data are still needed to substantiate this. The aim of this study is to compare the three surgical methods REZUM vs. HoLEP vs. TUR-P for endoscopic transurethral subvesical de-obstruction with regard to both subjective and objective voiding function, as well as improvements in quality of life and sexual function. The goal of the study is to work out the possible advantages and disadvantages for future patient counseling, thereby defining more precisely the role of these surgical procedures within the armamentarium of urology. This is a single-center, randomized, prospective interventional study.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
198

participants targeted

Target at P50-P75 for phase_4

Timeline
53mo left

Started Nov 2025

Longer than P75 for phase_4

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Nov 2025Oct 2030

First Submitted

Initial submission to the registry

September 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 2, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

November 15, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2026

Expected
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2030

Last Updated

November 19, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

September 24, 2025

Last Update Submit

November 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Non-inferiority of the surgical techniques in symptom improvement, determined by the change (delta) in the International Prostate Symptom Score (IPSS) at 1 month compared to baseline IPSS.

    1 month

Study Arms (3)

TURP

ACTIVE COMPARATOR
Procedure: Treatment BPH

HOLEP

ACTIVE COMPARATOR
Procedure: Treatment BPH

REZUM

ACTIVE COMPARATOR
Procedure: Treatment BPH

Interventions

Treatment BPHPROCEDURE

We compare 3 different types of BPH surgery - HoLEP vs. TURP vs. REZUM

HOLEPREZUMTURP

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Patients with confirmed benign prostatic syndrome for whom surgical therapy is indicated
  • Prostate volume between 30 and 80 ml

You may not qualify if:

  • Lack of capacity to give informed consent
  • Emergency surgeries
  • Known prostate carcinoma
  • Elevated post-void residual urine \> 300 ml
  • Neurogenic bladder emptying disorder
  • Urethral pathologies
  • High-intensity anticoagulation
  • Dual antiplatelet therapy
  • History of pelvic radiation
  • Chronic pelvic pain syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Prostatic Hyperplasia

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2025

First Posted

October 2, 2025

Study Start

November 15, 2025

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

October 15, 2030

Last Updated

November 19, 2025

Record last verified: 2025-09